{"SPADE_UN_16279": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16279", "Peptide Name": "AmphiArc3", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "AFRHSVKEELNYIRRRLERFPNRL", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (EC50>50 µM ); MCF-7 (EC50>50 µM )", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C138H223N47O35", "Mass": 3100.54, "PI": 11.34, "Net Charge": 5, "Hydrophobicity": -1.16, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "In silico design and optimization of selective membranolytic anticancer peptides", "Pubmed ID": "31375699", "Reference": "Sci Rep. 2019 Aug 2;9(1)11282.", "Author": "Gabernet G, Gautschi D, Müller AT, Neuhaus CS, Armbrecht L, Dittrich PS, Hiss JA, Schneider G.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31375699"}], "Frequent Amino Acids": "REL", "Absent Amino Acids": "CDGMOQTUW", "Basic Residues": 8, "Acidic Residues": 3, "Hydrophobic Residues": 10, "Polar Residues": 14, "Positive Residues": 8, "Negative Residues": 3, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17016", "Similarity": 0.6666666666666666, "Sequence": "RRRRRR"}, {"SPADE_ID": "SPADE_UN_17095", "Similarity": 0.6666666666666666, "Sequence": "RRRRRR"}, {"SPADE_ID": "SPADE_UN_17227", "Similarity": 0.6666666666666666, "Sequence": "RRRRRR"}]}}}